PainChek receives $1.049m R&D Tax Incentive Refund
Filed with ASX · · 2 pages · English
In the deck
Earlier from PainChek
- Ethos Laboratories Distribution Agreement
- AGM CEO Presentation
- Response to ASX Query
- PCK expands activities to Japan with JETRO business connect
- Financial Statements 30 June 2022 & Appendix 4E
Later from PainChek
- US nursing home study to pave way for FDA De Novo clearance
- PainChek A$3.55m Placement
- Response to ASX Price Query
- Quarterly Update and Appendix 4C
- Notice of Acceptance for European Patent
Follow PainChek into a list and get an email when it puts out news.
Follow PainChek